-
1
-
-
0031443792
-
The genetic revolution and physician's duty of confidentiality
-
Berry R.M. The genetic revolution and physician's duty of confidentiality. J Legal Med 18 (1977) 401
-
(1977)
J Legal Med
, vol.18
, pp. 401
-
-
Berry, R.M.1
-
2
-
-
0035700448
-
Some legal, social, and ethical issues related to the genetic testing revolution as exemplified in the long QT syndrome
-
Liebman J. Some legal, social, and ethical issues related to the genetic testing revolution as exemplified in the long QT syndrome. J Electrocardiol 34 Suppl (2001) 183-188
-
(2001)
J Electrocardiol
, vol.34
, Issue.SUPPL
, pp. 183-188
-
-
Liebman, J.1
-
3
-
-
0003107037
-
The implications of genetic testing for health and life insurance
-
Rothstein M.A. (Ed), Yale University Press, New Haven, CT
-
Kass N.E. The implications of genetic testing for health and life insurance. In: Rothstein M.A. (Ed). Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era (1997), Yale University Press, New Haven, CT 299-315
-
(1997)
Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era
, pp. 299-315
-
-
Kass, N.E.1
-
4
-
-
33847765415
-
Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up
-
Foster C., Watson M., Feles R., et al. Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. Br J Cancer 96 (2007) 718-724
-
(2007)
Br J Cancer
, vol.96
, pp. 718-724
-
-
Foster, C.1
Watson, M.2
Feles, R.3
-
5
-
-
1842427366
-
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a single gold standard test?
-
Corrado D., and Thiene G. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a single gold standard test?. J Cardiovasc Electrophysiol 15 (2004) 307-309
-
(2004)
J Cardiovasc Electrophysiol
, vol.15
, pp. 307-309
-
-
Corrado, D.1
Thiene, G.2
-
6
-
-
19944433030
-
The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)
-
Hodgkinson K.A., Parfrey P.S., Bassett A.S., et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 45 (2005) 400-408
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 400-408
-
-
Hodgkinson, K.A.1
Parfrey, P.S.2
Bassett, A.S.3
-
7
-
-
4544245238
-
The "Duty to Warn": a patient's family about hereditary disease risks
-
Offit K., Groeger E., Turner J.D., et al. The "Duty to Warn": a patient's family about hereditary disease risks. JAMA 29292 (2004) 1469-1473
-
(2004)
JAMA
, vol.29292
, pp. 1469-1473
-
-
Offit, K.1
Groeger, E.2
Turner, J.D.3
-
8
-
-
33644795291
-
Genetic knowledge and moral responsibility: ambiguity at the interface of genetic research and clinical practice
-
Pullman D., and Hodgkinson K. Genetic knowledge and moral responsibility: ambiguity at the interface of genetic research and clinical practice. Clin Genet 69 (2006) 199-203
-
(2006)
Clin Genet
, vol.69
, pp. 199-203
-
-
Pullman, D.1
Hodgkinson, K.2
-
9
-
-
33750388916
-
The emergence of an ethical duty to disclose genetic research results: international perspectives
-
Knoppers B.M., Joly Y., Simard J., and Durocher F. The emergence of an ethical duty to disclose genetic research results: international perspectives. Eur J Hum Genet 14 (2006) 1170-1178
-
(2006)
Eur J Hum Genet
, vol.14
, pp. 1170-1178
-
-
Knoppers, B.M.1
Joly, Y.2
Simard, J.3
Durocher, F.4
|